This cohort contained a subset of genes that could be considered potential biomarkers for breast cancer progression, including FOXA1, MLPH, ESR1, AR, GATA3, TFF1, THSD4, and TBC1D9 (Supplementary Figure S2B). Here, MLPH is linked to breast carcinoma.